Phathom Pharmaceuticals Inc (PHAT)
11.87
+0.17
(+1.45%)
USD |
NASDAQ |
Jun 18, 16:00
11.85
-0.02
(-0.17%)
After-Hours: 20:00
Phathom Pharmaceuticals Total Assets (Quarterly): 356.50M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 356.50M |
| December 31, 2023 | 413.84M |
| September 30, 2023 | 236.99M |
| June 30, 2023 | 265.04M |
| March 31, 2023 | 144.01M |
| December 31, 2022 | 164.81M |
| September 30, 2022 | 201.93M |
| June 30, 2022 | 213.50M |
| March 31, 2022 | 149.05M |
| December 31, 2021 | 189.43M |
| September 30, 2021 | 228.38M |
| Date | Value |
|---|---|
| June 30, 2021 | 214.58M |
| March 31, 2021 | 246.36M |
| December 31, 2020 | 295.11M |
| September 30, 2020 | 230.89M |
| June 30, 2020 | 252.42M |
| March 31, 2020 | 263.92M |
| December 31, 2019 | 257.18M |
| September 30, 2019 | 79.71M |
| June 30, 2019 | 84.88M |
| December 31, 2018 | 0.902M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
79.71M
Minimum
Sep 2019
413.84M
Maximum
Dec 2023
224.43M
Average
229.63M
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 34.37B |
| Rhythm Pharmaceuticals Inc | 258.65M |
| Xeris Biopharma Holdings Inc | 336.62M |
| Kodiak Sciences Inc | 434.76M |
| Biomea Fusion Inc | 168.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 505.00M |
| Shareholders Equity (Quarterly) | -148.50M |
| Debt to Equity Ratio | -1.004 |
| Current Ratio | 7.831 |